GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+7.91%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$388M
AUM Growth
+$388M
(+15%)
Cap. Flow
+$40.8M
Cap. Flow
% of AUM
10.53%
Top 10 Holdings %
Top 10 Hldgs %
49.94%
Holding
61
New
17
Increased
14
Reduced
13
Closed
10
Top Buys
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$17.6M |
| 2 |
Invesco CurrencyShares Swiss Franc Trust
FXF
|
$12.3M |
| 3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$10.7M |
| 4 |
Travere Therapeutics
TVTX
|
$10.1M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$9.92M |
Top Sells
| 1 |
Mersana Therapeutics
MRSN
|
$10.7M |
| 2 |
Arrowhead Research
ARWR
|
$9.52M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$8.74M |
| 4 |
Exelixis
EXEL
|
$8.61M |
| 5 |
PTC Therapeutics
PTCT
|
$8.23M |
Sector Composition
| 1 | Healthcare | 82.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
51
DELISTED
Audentes Therapeutics, Inc
BOLD
| – | – |
-125,000
| Closed | -$4.78M |
|
|
ADMS
52
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| – | – |
-295,000
| Closed | -$7.62M |
|
|
ACOR
53
DELISTED
Acorda Therapeutics, Inc.
ACOR
| – | – |
-33,000
| Closed | -$947K |
|
54
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
55
Puma Biotechnology
PBYI
$258M
| – | – |
-14,000
| Closed | -$828K |
|
56
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-360,000
| Closed | -$4.61M |
|
|
57
Exelixis
EXEL
$9.95B
| – | – |
-400,000
| Closed | -$8.61M |
|
|
58
Arrowhead Research
ARWR
$3.84B
| – | – |
-700,000
| Closed | -$9.52M |
|
|
TECX
59
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| – | – |
-230,000
| Closed | -$6.57M |
|
|
60
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-600,000
| Closed | -$10.7M |
|
|
LCI
61
DELISTED
Lannett Company, Inc.
LCI
| – | – |
-250,000
| Closed | -$3.4M |
|